JSPR
Jasper Therapeutics Inc
0.5854$
+3.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.5% | +1.8% | +3.8% | +80.9% | -54.7% | +13.9% | -7.5% | -11.2% | +26.6% | -92.8% | +0.0% | – | |
| – | -17.0% | +0.9% | +26.8% | +34.8% | -1.4% | -8.1% | +0.3% | -21.6% | +16.6% | -74.5% | +80.6% | – | |
| – | -134.5% | – | – | +93.7% | -57.2% | -567.4% | – | -102.1% | – | – | – | – | |
| – | – | -89.1% | +528.0% | +74.5% | -65.0% | -100.0% | – | -100.0% | – | – | – | – | |
| – | – | -89.1% | +528.0% | +74.5% | -72.3% | – | -75.0% | +7,500.0% | +0.0% | – | – | – | |
| – | – | – | – | – | +600.0% | – | – | – | – | – | – | – | |
| – | -852.8% | – | -99.6% | -95.0% | +3,733.3% | -100.0% | – | +360.6% | -101.2% | – | – | – | |
| – | – | – | -136.9% | – | – | – | – | – | -295.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.